Angiotensin-converting enzyme gene insertion/deletion polymorphism in patients with chronic pancreatitis and pancreatic cancer

Digestive Surgery

Volumn 28, Issue 4, 2011, Pages 258-262

  Lukic, Snezana ^a   Nikolic, Aleksandra ^b   Alempijevic, Tamara ^a,c   Popovic, Dragan ^a,c   Sokic Milutinovic, Aleksandra ^a,c   Ugljesic, Milenko ^a,c   Knezevic, Srbislav ^a,c   Milicic, Biljana ^c   Dinic, Dragica ^b   Radojkovic, Dragica ^b  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b Laboratory for Molecular Genetics of Industrial Microorganisms   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Angiotensin converting enzyme; Chronic pancreatitis; Pancreatic cancer

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGE; AGED; CHRONIC PANCREATITIS; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; PANCREAS TUMOR; REVIEW; RISK; SEX DIFFERENCE; SMOKING; STATISTICAL MODEL;

ADULT; AGE FACTORS; AGED; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PANCREATIC NEOPLASMS; PANCREATITIS, CHRONIC; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; SEX FACTORS; SMOKING;

EID: 79957930570     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000328666     Document Type: Review

References (35)

1. Lowenfels AB, Maisonneuve P: Epidemiology and risk factors for pancreatic cancer. Best Pract Res Clin Gastroenterol 2006; 20: 197-209.
2. Curado MP, Edwards B, Shin HR, et al: Cancer Incidence in Five Continents. Lyons, IARC, 2007, vol 9, IARC Scientific Publications No. 160.
3. World Cancer Research Fund, American Institute for Cancer Research: Food, Nutrition and the Prevention of Cancer: a Global Perspective. Washington, American Institute for Cancer Research, 1997.
4. Silverman DT: Risk factors for pancreatic cancer: a case-control study based on direct interviews. Teratog Carcinog Mutagen 2001; 21: 7-25.
5. Coughlin SS, Calle EE, Patel AV, et al: Predictors of pancreatic cancer mortality among a large cohort of United States adults. Cancer Causes Control 2000; 11: 915-923. (Pubitemid 32005303)
6. Iodice S, Gandini S, Maisonneuve P, Lowenfels AB: Tobacco and risk of pancreatic cancer: a review and meta-analysis. Langenbecks Arch Surg 2008; 393: 535-545.
7. Yadav D, Whitcomb DC: The role of alcohol and smoking in pancreatitis. Nat Rev Gastroenterol Hepatol 2010; 7: 131-145.
8. Yadav D, Hawes RH, Brand RE, Anderson MA, Money ME, Banks PA, Bishop MD, Baillie J, Sherman S, DiSario J, Burton FR, Gardner TB, Amann ST, Gelrud A, Lawrence C, Elinoff B, Greer JB, O'Connell M, Barmada MM, Slivka A, Whitcomb DC, North American Pancreatic Study Group: Alcohol consumption, cigarette smoking, and the risk of recurrent acute and chronic pancreatitis. Arch Intern Med 2009; 169: 1035-1045.
9. Pezzili R: Etiology of chronic pancreatitis: has it changed in the last decade? World J Gastroenterol 2009; 15: 4737-4740.
10. Stroth U, Unger T: The renin angiotensin system and its receptors. J Cardiovasc Pharmacol 1999; 33:S21-S28. (Pubitemid 29072062)
11. Pueyo ME , N'Diaye N, Michel JB: Angiotensin II elicited signal transduction via AT 1 receptors in endothelial cells. Br J Pharmacol 1996; 118: 79-84. (Pubitemid 26135140)
12. Leung PS: The peptide hormone angiotensin II: its new functions in tissues and organs. Curr Protein Pept Sci 2004; 5: 267-273.
13. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F: An insertion/deletion polymorphism in the angiotensin Iconverting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-1346. (Pubitemid 20370444)
14. Cambien F, Poirier O, Lecerf L, et al: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359: 641-644.
15. Leung PS: The physiology of a local reninangiotensin system in the pancreas. J Physiol 2007; 580: 31-37. (Pubitemid 46470642)
16. Kuno A, Yamada T, Masuda K, Ogawa K, Sogawa M, Nakamura S, Nakazawa T, Ohara H, Nomura T, Joh T, Shirai T, Itoh M: Angiotensin-converting enzyme inhibitor attenuates pancreatic inflammation and fibrosis in male Wistar Bonn/Kobori rats. Gastroenterology 2003; 124: 1010-1019. (Pubitemid 36389804)
17. Arafat HA, Gong Q, Chipitsyna G, Rizvi A, Saa CT, Yeo CJ: Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma. J Am Coll Surg 2007; 204: 996-1005. (Pubitemid 46661215)
18. Egami K, Murohara T, Shimada T, Sasaki K, Shintani S, Sugaya T, Ishii M, Akagi T, Ikeda H, Matsuishi T, Imaizumi T: Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. J Clin Invest 2003; 112: 67-75. (Pubitemid 38056377)
19. Arrieta O, Guevara P, Escobar E, García-Navarrete R, Pineda B, Sotelo J: Blockage of angiotensin II type I receptor decreases the synthesis of growth factors and induces apoptosis in C6 cultured cells and C6 rat glioma. Br J Cancer 2005; 92: 1247-1252. (Pubitemid 40604399)
20. Lever AF, Hole DJ, Gillis CR, et al: Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet 1998; 352: 179-184. (Pubitemid 28327802)
21. Reddy MK, Baskaran K, Molteni A: Inhibitors of angiotensin-converting enzyme modulate mitosis and gene expression in pancreatic cancer cells. Proc Soc Exp Biol Med 1995; 210: 221-226. (Pubitemid 26020247)
22. Chua CC, Hamdy RC, Chua BH: Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells. Biochem Biophys Acta 1998; 1410: 187-194. (Pubitemid 28129101)
23. Korc M: Pathways for aberrant angiogenesis in pancreatic cancer. Mol Cancer 2003; 7: 2-8.
24. Kim DS, Choi SI, Lee HS, Park JK, Yi HK: Determination of human angiotensin converting enzyme (ACE) gene polymorphisms in erectile dysfunction: frequency differences of ACE gene polymorphisms according to the method of analysis. Clin Chem Lab Med 2001; 39: 11-14. (Pubitemid 32186272)
25. Curado MP, Edwards B, Shin HR, et al: Cancer Incidence in Five Continets. Lyons: IARC, 2007, vol 9, IARC Scientific Publ No. 160.
26. Lankish PG, Assmus C, Maisonneuve P, Lowenfels AB: Epidemiology of pancreatic diseases in Luneburg County a study in a defined German population. Pancreatolology 2002; 2: 469-477. (Pubitemid 36151343)
27. Couhlin SS, Calle EE, Patel AV, Thun MJ: Predictors of pancreatic cancer mortality among a large cohort of United States adults. Cancer Causes Control 2000; 11: 915-923. (Pubitemid 32005303)
28. Iodice S, Gandini S, Maisonneuve P, Lowenfels AB: Tobacco and risk of pancreatic cancer: a review and meta-analysis. Langenbecks Arch Surg 2008; 393: 535-545.
29. Lyon JL, Slattery ML, Mahoney AW, Robison LM: Dietary intake as a risk factor for cancer of the exocrine pancreas Cancer Epidemiol Biomarkers Prev 1993; 2: 513-518.
30. Silverman DT: Risk factors for pancreatic cancer: a case-control study based on direct interviews. Teratog Carcinog Mutagen 2001; 21: 7-25.
31. Stolzenberg-Solomon RZ, Pietinen P, Taylor PR, Virtamo J, Albanes D: Prospective study of diet and pancreatic cancer in male smokers. Am J Epidemiol 2002; 155: 783-792. (Pubitemid 34456987)
32. Oruc N, et al: The functional angiotensin converting enzyme gene I/D polymorphism does not alter susceptibility of chronic pancreatitis. J Pancreas 2004; 5: 457-463. (Pubitemid 41573848)
33. Hucl T, et al: Angiotensin-converting enzyme insertion/deletion polymorphism in patients with acute and chronic pancreatitis. Eur J Gastroenterol Hepatol 2009; 21: 1032-1035.
34. Bhaskar S, et al: Lack of significant association of an insertion/deletion polymorphism in the angiogenesis converting enzyme (ACE) gene with tropical calcific pancreatitis. BMC Gastroenterol 2006; 6: 42.
35. Fendrich V, Chen NM, Neef M, Waldmann J, Buchholz M, Feldmann G, Slater EP, Maitra A, Bartsch DK: The angiotensin-Iconverting enzyme inhibitor enalapril and aspirin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of panceratic cancer. Gut 2010; 59: 630-637.